George Stuart
About George Stuart
George Stuart is the Chief Operating Officer at Aegis Therapeutics LLC, with a distinguished career spanning over 30 years in the pharmaceutical and biotechnology sectors.
George Stuart Aegis Therapeutics LLC
George Stuart currently holds the position of Chief Operating Officer at Aegis Therapeutics LLC. His role encompasses overseeing the company's operations and ensuring efficiency across various departments. With extensive experience in the specialty pharmaceutical and biotechnology sectors, Stuart brings valuable insights and leadership to Aegis Therapeutics.
George Stuart Education and Expertise
George Stuart graduated from San Diego State University with a bachelor of science degree in accounting. This educational background laid the foundation for his career in financial management and executive roles within the pharmaceutical and biotechnology industries. Over the course of more than 30 years, Stuart has honed his expertise in financial operations, strategic planning, and executive leadership.
George Stuart Background
George Stuart has cultivated a robust background in the pharmaceutical and biotechnology industries, accumulating over 20 years of experience in these sectors. His career began at Deloitte, where he served as Senior Manager. Subsequently, he advanced into executive roles at various companies, including Ligand Pharmaceuticals, Xcel Pharmaceuticals, Questcor Pharmaceuticals, and Neurelis. Stuart's extensive background supports his current role as Chief Operating Officer at Aegis Therapeutics LLC.
George Stuart Career at Questcor Pharmaceuticals
At Questcor Pharmaceuticals, George Stuart served as Senior Vice President and Chief Financial Officer. In this capacity, he was responsible for overseeing the company's financial health, including budgeting, financial planning, and reporting. Stuart's financial acumen and leadership contributed to Questcor's strategies and operations during his tenure.
George Stuart Career Achievements
George Stuart's career spans several key positions in the pharmaceutical and biotechnology industries. As a part of the founding team at Xcel Pharmaceuticals, he held the role of Vice President and Chief Financial Officer. He has also led financial teams at Neurelis, Questcor Pharmaceuticals, and Ligand Pharmaceuticals. His management roles at these companies reflect a significant contribution to their growth and operational efficiency.